GMP IPO Watch
The Wealth Company Mid Cap Fund
Direct Plan · Growth · The Wealth Company Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +3.85% | +3.57% | 9 of 34 |
| 1M | +0.98% | +0.82% | 21 of 34 |
| YTD | -4.89% | +0.39% | 28 of 34 |
| INCEPTION | -18.41% | — | — |
Ranked among: Equity Scheme - Mid Cap Fund.
NAV History
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity89.43%
- Debt0.00%
- Cash10.53%
- Other0.04%
Market Cap Split
- Large Cap5.62%
- Mid Cap69.67%
- Small Cap14.14%
- Others10.57%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 32.67 | 31.89 |
| P/B | 4.00 | 4.65 |
| Price / Sales | 2.68 | 3.55 |
| Price / Cash Flow | 24.25 | 24.17 |
| Dividend Yield (%) | 0.76 | 0.75 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| The Clearing Corporation of India Ltd. 01-OCT-2026 | Net Current Assets | 10.33% | — |
| Indian Hotels Company | Leisure Services | 6.02% | -0.16% |
| GE Vernova T&D | Electrical Equipment | 4.88% | -0.32% |
| Dixon Technologies | Consumer Durables | 4.79% | +1.92% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 4.29% | +0.57% |
| HDFC Bank | Banks | 4.11% | -0.04% |
| Balkrishna Industries | Auto Components | 3.68% | +1.01% |
| ITC Hotels | Leisure Services | 3.64% | +0.26% |
| Swiggy | Retailing | 3.63% | +0.00% |
| ICICI Prudential Life Insurance | Insurance | 3.09% | -0.54% |
| 360 One WAM | Capital Markets | 2.69% | +0.28% |
| Prestige Estates Projects | Realty | 2.58% | +0.67% |
| MRF | Auto Components | 2.55% | -0.19% |
| Voltas | Consumer Durables | 2.48% | — |
| Crompton Greaves | Consumer Durables | 2.30% | -0.32% |
View all 46 holdings
| Endurance Technologies | Auto Components | 2.16% | — |
| Biocon | Pharmaceuticals & Biotechnology | 2.15% | — |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.03% | +1.01% |
| BASF | Chemicals & Petrochemicals | 2.00% | -0.22% |
| Thermax | Electrical Equipment | 1.97% | — |
| Tube Investment | Auto Components | 1.94% | -0.35% |
| Niva Bupa Health Insurance Company | Insurance | 1.79% | -0.18% |
| Fortis Healthcare | Equity | 1.79% | -0.33% |
| Amber Enterprises | Consumer Durables | 1.74% | -0.27% |
| Alembic Pharmaceuticals | Pharmaceuticals & Biotechnology | 1.71% | -0.49% |
| Lupin | Pharmaceuticals & Biotechnology | 1.65% | +0.75% |
| Blue Dart Express | Transport Services | 1.61% | -0.12% |
| Max Financial Services | Insurance | 1.59% | -0.25% |
| IRCTC | Leisure Services | 1.59% | -0.10% |
| Godrej Consumer Products | Personal Products | 1.51% | — |
| Havells | Consumer Durables | 1.47% | — |
| Godrej Industries | Diversified | 1.39% | — |
| NMDC | Minerals & Mining | 1.33% | -0.22% |
| Dabur India | Personal Products | 1.10% | -0.02% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 1.06% | -0.05% |
| Syngene International | Equity | 1.06% | — |
| NALCO | Non - Ferrous Metals | 0.99% | -0.13% |
| SKF India | Auto Components | 0.88% | -0.03% |
| APL Apollo Tubes | Industrial Products | 0.61% | -1.61% |
| AIA Engineering | Industrial Products | 0.44% | — |
| Asset Reconstruction Company | Finance | 0.42% | — |
| ICRA | Capital Markets | 0.36% | — |
| Chemplast Sanmar | Chemicals & Petrochemicals | 0.22% | +0.12% |
| Net Receivable/Payable | Net Current Assets | 0.20% | — |
| One 97 Communications | Financial Technology (Fintech) | 0.09% | +0.00% |
| TVS Supply Chain Solutions | Transport Services | 0.05% | +0.00% |
Sector Allocation · Sep 2026
View all 20 sectors
Risk Metrics
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 3Y | -371.24 | -13.20 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
WhiteOak Capital Mid Cap Fund
Direct Plan · IDCW Option
|
+6.44% | +20.80% | — | +21.53% |
|
BANDHAN MID CAP FUND
Direct Plan · IDCW
|
+6.34% | +18.03% | — | +17.79% |
|
Helios Mid Cap Fund
Direct Plan · IDCW
|
+5.44% | — | — | +21.17% |
|
ICICI Prudential Mid Cap Fund
Regular Plan · Growth
|
+5.23% | +19.51% | +14.44% | +13.20% |
|
Axis Midcap Fund
Regular Plan · Growth Option
|
+3.95% | +15.81% | +11.07% | +17.16% |
|
JM Mid Cap Fund
Regular Plan · Growth Option
|
+3.90% | +16.24% | — | +19.49% |
|
HSBC Midcap Fund
Regular Plan · IDCW
|
+3.57% | +10.65% | — | +11.16% |
|
Invesco India Mid Cap Fund
Regular Plan · Growth
|
+3.51% | +21.43% | +16.53% | +16.27% |
|
Union Midcap Fund
Regular Plan · Growth Option
|
+2.98% | +14.93% | +12.46% | +27.09% |
|
Taurus Mid Cap Fund
Regular Plan · Growth
|
+2.01% | +9.90% | +10.75% | +10.62% |
More From Wealth Company Asset Management Holdings Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
The Wealth Company Liquid Fund
Direct Plan · Growth
|
+6.55% | — | — | +6.52% |
|
The Wealth Company Arbitrage Fund
Direct Plan · Growth
|
+6.37% | — | — | +6.37% |
|
The Wealth Company Flexi Cap Fund
Direct Plan · Growth
|
-3.09% | — | — | -3.04% |
|
THE WEALTH COMPANY ETHICAL FUND
Direct Plan · IDCW
|
-4.43% | — | — | -5.05% |
|
The Wealth Company Multi Cap Fund
Direct Plan · IDCW
|
— | — | — | -6.67% |
|
The Wealth Company Large & Mid Cap Fund
Regular Plan · Growth
|
— | — | — | -5.99% |
|
The Wealth Company Small Cap Fund
Direct Plan · IDCW
|
— | — | — | +27.54% |
|
The Wealth Company Balanced Advantage Fund
Direct Plan · IDCW
|
— | — | — | -2.74% |
|
The Wealth Company Gold ETF FOF
Regular Plan · IDCW
|
— | — | — | -11.40% |
|
The Wealth Company Gold ETF
Regular Plan · Growth
|
— | — | — | +4.72% |
About This Scheme
Investment Objective
To provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. There is no assurance that the investemnt objective of the scheme will be achieved.
Stated Asset Allocation
Equity & Equity related Instruments of Mid Cap Companies: 65% - 100% Equity & Equity related Instruments other than Mid Cap Companies:0% - 35% Money market instruments (including cash & cash equivalents) and other liquid instruments): 0% - 35% Gold and Silver ETFs: 0% - 5% Units Issued by INVITS: 0% - 10%
Exit Load
1% - If redeemed/switched out within 180 days from the date of allotment. Nil - if redeemed/switched out after 180 days from the date of allotment
Fund Managers
FM -1 Mr. Chinmay Sathe, FM - 2 Ms. Aparna Shanker
FM 1 - Primary (Equity portion) , FM 2 - Primary (Equity portion)
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.